Markets

The speed at which gold has broken above US$2,000 an ounce has left some in the market fearing a correction, but many analysts predict more gains as the coronavirus crisis spurs investors to buy into bullion's relative safety.

The United States government will pay Johnson & Johnson over US$1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.

Twitter Inc said on Wednesday it has fixed a security issue that could allow hackers to access private Twitter data of some Android users, including messages.

SINGAPORE: Another 47 employers - most of which are from the financial and professional services sectors - have been placed on a watchlist of companies with suspected discriminatory hiring practices, said the Ministry of Manpower (MOM) on Wednesday (Aug 5). The 47 companies collectively hire about ...

U.S. private employers hired far fewer workers than expected in July as companies exhausted loans to help with wages and new COVID-19 infections flared up across the country, supporting the view that the nascent economic recovery was faltering.

Boeing Co does not see the need to add to liquidity through additional debt offerings to manage the downturn in global aviation caused by the COVID-19 pandemic, chief financial officer Greg Smith said on Wednesday.

The White House Office of Science and Technology Policy said on Wednesday the Trump administration is launching a national education partnership to expand access to K-12 quantum information science (QIS) education with major companies and research institutions.

Samsung Electronics Co Ltd unveiled its latest Galaxy Note smartphone on Wednesday hoping to regain ground against rivals Huawei and Apple as the smartphone market begins to recover from its COVID-19 slump.

U.S. private payrolls growth slowed sharply in July, pointing to a loss of momentum in the labor market and overall economic recovery as new COVID-19 infections spread across the country.

OTTAWA: Pharmaceutical giant Pfizer and German biotech firm BioNTech on Wednesday (Aug 5) said they had signed a deal to supply Canada with an experimental coronavirus vaccine. Deliveries of the BNT162 mRNA-based vaccine candidate are planned over the course of 2021, subject to clinical success ...